Association of anthropometric characteristics with the risk of malignant lymphoma and plasma cell myeloma in a Japanese population: A population-based cohort study

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 6, 2010, Pages 1623-1631

  Kanda, Junya ^a,d   Matsuo, Keitaro ^a,b   Inoue, Manami ^c   Iwasaki, Motoki ^c   Sawada, Norie ^c   Shimazu, Taichi ^c   Yamaji, Taiki ^c   Sasazuki, Shizuka ^c   Tsugane, Shoichiro ^c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; BODY HEIGHT; BODY SIZE; JAPAN; LYMPHOMA; MIDDLE AGED; PROSPECTIVE STUDY;

SOMATOMEDIN;

ADULT; AGED; ANTHROPOMETRY; BODY HEIGHT; BODY SIZE; BODY WEIGHT; COHORT STUDIES; FEMALE; HUMANS; JAPAN; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROSPECTIVE STUDIES; SOMATOMEDINS;

EID: 77953315488     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0171     Document Type: Article

References (33)

1. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. IARC Scientific Publications No. 160. Lyon: IARC Press; 2007.
2. Waterhouse J, Muir CS, Shanmugaratnam K, Powell J. Cancer incidence in five continents, Vol. IV. IARC Scientific Publications No. 42. Lyon: IARC Press; 1982.
3. Crimmins EM, Finch CE. Infection, inflammation, height, and longevity. Proc Natl Acad Sci U S A 2006;103:498-503.
4. Gordon-Larsen P, The NS, Adair LS. Longitudinal trends in obesity in the United States from adolescence to the third decade of life. Obesity (Silver Spring). In press 2009.
5. Pylypchuk RD, Schouten LJ, Goldbohm RA, Schouten HC, van den Brandt PA. Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol 2009;170:297-307.
6. Maskarinec G, Erber E, Gill J, Cozen W, Kolonel LN. Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2008;17:196-203. (Pubitemid 351196291)
7. Britton JA, Khan AE, Rohrmann S, et al. Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica 2008;93:1666-77.
8. Lu Y, Prescott J, Sullivan-Halley J, et al. Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California Teachers Study. Am J Epidemiol 2009;170:1231-40.
9. Cerhan JR, Bernstein L, Severson RK, et al. Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2005;16:1203-14.
10. Cerhan JR, Janney CA, Vachon CM, et al. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 2002;156:527-35.
11. MacInnis RJ, English DR, Hopper JL, Giles GG. Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst 2005;97:1154-7.
12. Chang ET, Hjalgrim H, Smedby KE, et al. Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 2005;97:210-8.
13. Larsson SC, Wolk A. Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis. Int J Cancer 2007;121:1564-70.
14. Willett EV, Morton LM, Hartge P, et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 2008;122:2062-70.
15. Chung S, Song MY, Shin HD, et al. Korean and Caucasian overweight premenopausal women have different relationship of body mass index to percent body fat with age. J Appl Physiol 2005;99:103-7.
16. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2008;38:641-8.
17. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
18. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 2000;50:696-702.
19. Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695-708.
20. Sung J, Song YM, Lawlor DA, Smith GD, Ebrahim S. Height and site-specific cancer risk: a cohort study of a Korean adult population. Am J Epidemiol 2009;170:53-64.
21. Kanda J, Matsuo K, Suzuki T, et al. Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. Int J Cancer 2010;126:2416-2425.
22. Oh SW, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 2005;23:4742-54.
23. Song YM, Sung J, Ha M. Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 2008;26:3395-402.
24. Tsugane S, Sobue T, Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Diseases. Baseline survey of JPHC study-design and participation rate. J Epidemiol 2001;11:S24-9.
25. Watanabe S, Tsugane S, Sobue T, Konishi M, Baba S, Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Diseases. Study design and organization of the JPHC study. J Epidemiol 2001;11:S3-7.
26. Steering Committee of the WHO Western Pacific Region IASO & IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. pp. 15-21 Australia: Health Communications Australia Pty Ltd.; 2000.
27. WCRF. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. 2nd ed. Washington (DC): American Institute for Cancer Research; 2007. p. 210-38.
28. Kanda J, Matsuo K, Inoue M, et al, Japan Public Health Center-Based Prospective Study. Association of alcohol intakewith the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study. Cancer Epidemiol Biomarkers Prev 2010;19:429-34.
29. Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007;7:266-81.
30. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000;21:215-44.
31. Mitsiades CS, Mitsiades NS, McMullan CJ, et al. Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell 2004;5:221-30.
32. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev 2001;22:53-74.
33. Inoue M, Sobue T, Tsugane S. Impact of body mass index on the risk of total cancer incidence and mortality among middle-aged Japanese: data from a large-scale population-based cohort study-the JPHC study. Cancer Causes Control 2004;15:671-80.